SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-046028
Filing Date
2021-07-08
Accepted
2021-07-08 18:15:57
Documents
1
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14660
  Complete submission text file 0001209191-21-046028.txt   16009
Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 210 RIDGE MCINTIRE ROAD, SUITE 350 CHARLOTTESVILLE VA 22903
Business Address
Hardie Robert D. (Reporting) CIK: 0001804350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 211081202